The New England journal of medicine, 2019-10, Vol.381 (18), p.1718-1727
2019
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
- Ist Teil von
- The New England journal of medicine, 2019-10, Vol.381 (18), p.1718-1727
- Ort / Verlag
- United States: Massachusetts Medical Society
- Erscheinungsjahr
- 2019
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- In patients with a progressive interstitial lung disease, 62% of whom had a CT pattern of usual interstitial pneumonia, those who received nintedanib had a lower annual rate of decline in the forced vital capacity than those who received placebo at 52 weeks.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0028-4793eISSN: 1533-4406DOI: 10.1056/NEJMoa1908681Titel-ID: cdi_proquest_journals_2310710388
- Format
- –
- Schlagworte
- Aged, Carbon monoxide, Computed tomography, Diarrhea, Diarrhea - chemically induced, Disease Progression, Double-Blind Method, Female, Fibrosis, Genotype & phenotype, Humans, Idiopathic Pulmonary Fibrosis - drug therapy, Idiopathic Pulmonary Fibrosis - physiopathology, Indoles - adverse effects, Indoles - therapeutic use, Lung diseases, Male, Middle Aged, Patients, Protein Kinase Inhibitors - adverse effects, Protein Kinase Inhibitors - therapeutic use, Pulmonary fibrosis, Quality of life, Questionnaires, Technical communication, Tyrosine, Vital Capacity - drug effects